Los puntos clave no están disponibles para este artículo en este momento.
Higher doses of PEG-asparaginase failed to improve outcome, but additional intrathecal therapy during early induction seemed to contribute to improved CNS control without excessive toxicity for high-risk patients.
Jeha et al. (Mon,) studied this question.